Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection

Fidaxomicin causes less disruption of anaerobic microbiota during treatment of Clostridium difficile infection (CDI) than vancomycin and has activity against many vancomycin-resistant enterococci (VRE). In conjunction with a multicenter randomized trial of fidaxomicin versus vancomycin for CDI treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nerandzic, Michelle M., Mullane, Kathleen, Miller, Mark A., Babakhani, Farah, Donskey, Curtis J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Supplement Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388028/
https://ncbi.nlm.nih.gov/pubmed/22752860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis440
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados